AmerisourceBergen completed the acquisition of PharmaLex from AUCTUS Capital Partners for €1.28bn.

AmerisourceBergen, a provider of drug distribution and consulting services provider, completed the acquisition of PharmaLex, a provider of specialized services for the pharma, biotech and medtech industries, from AUCTUS Capital Partners, a private equity firm, for €1.28bn ($1.29bn). “The strategic acquisition of PharmaLex will expand our global platform of biopharma services, further advancing the strategy we detailed at our recent Investor Day. AmerisourceBergen is committed to building on our leadership in specialty services through a continued focus on innovation and partnerships, and by acquiring PharmaLex, we will be able to further enhance our value proposition to pharmaceutical manufacturers, from emerging biotechs to global biopharmaceutical leaders. We look forward to welcoming the PharmaLex team to create healthier futures with AmerisourceBergen," Steven H. Collis, AmerisourceBergen Chairman, President & CEO.